The only medical cannabis conference created to answer the serious questions behind all things cannabis and cannabinoid in the EU.
Forums and Events cordially invite you to participate in the most exciting topic to hit the medical and business industry in the past 20+ years!
Since the onset of legalization of medical cannabis in Germany, there are still many unknowns concerning the impact it will have on the scientific & medical implications for patients. Secondary to this are the issues surrounding the clarity of laws and legislation concerning everything from licensing, to regulations for both producers and end users. There is intense global interest in business opportunities from both an investment and development side as well. These are just a few of the bigger topics being explored. More importantly and possibly the biggest question of them all is:
Where do we go from here?
Join us this November 15th & 16th in Frankfurt Am Main for a thought provoking and proactive oriented conference. This is an invaluable opportunity for the diversified members of the cannabis industry to come together and network, learn about the trade and get answers!
Don't forget the 10% discount code CAN10RMY.
We will explore the medical implications of cannabis products for patient treatment in areas such as cancer, epilepsy, glaucoma, HIV/AIDS, post-traumatic stress disorder (PTSD), amyotrophic lateral sclerosis (ALS), Crohn’s disease, Parkinson’s disease, as well as multiple sclerosis. The list just keeps getting longer.
Lecturers from the scientific community will discuss and present their latest cannabinoid research and development findings.
The conference will also concentrate on business development, investment opportunities, and collaborative projects to shed light on how it will all impact the European market as a whole.
We thank you in advance for your patronage. Please share this information with anyone you think would benefit.
Don't forget the 10% discount code CAN10RMY